Endovia Health Sciences, Inc. (EDVA) SEC filings

EDVANYSEBeveragesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30

$0.18+0.02 (+13.45%)

Close on Nov 13, 2026Market cap $137.15KP/E –Yield –

SEC filings

40 of Endovia Health Sciences's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Proxy statement	DEF 14A	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Current report	8-K	Oct 22, 2026	Oct 27, 2026	SEC EDGAR
Current report	8-K	Oct 15, 2026	Oct 15, 2026	SEC EDGAR
Current report	8-K	Sep 30, 2026	Oct 6, 2026	SEC EDGAR
Proxy statement	DEF 14A	Oct 5, 2026	Oct 5, 2026	SEC EDGAR
Current report	8-K	Oct 5, 2026	Oct 5, 2026	SEC EDGAR
Current report	8-K	Sep 18, 2026	Sep 24, 2026	SEC EDGAR
Current report	8-K	Sep 22, 2026	Sep 22, 2026	SEC EDGAR
Current report	8-K	Aug 31, 2026	Aug 31, 2026	SEC EDGAR
Current report	8-K	Aug 25, 2026	Aug 28, 2026	SEC EDGAR
Current report	8-K	Aug 20, 2026	Aug 26, 2026	SEC EDGAR
Current report	8-K	Aug 24, 2026	Aug 25, 2026	SEC EDGAR
Current report	8-K	Aug 21, 2026	Aug 21, 2026	SEC EDGAR
Current report	8-K	Aug 20, 2026	Aug 20, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 19, 2026	SEC EDGAR
Current report	8-K	Aug 12, 2026	Aug 12, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 11, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Jul 31, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Jul 28, 2026	Jul 29, 2026	SEC EDGAR
Current report	8-K	Jul 15, 2026	Jul 21, 2026	SEC EDGAR
Current report	8-K	Jul 16, 2026	Jul 16, 2026	SEC EDGAR
Current report	8-K	Jul 14, 2026	Jul 14, 2026	SEC EDGAR
Current report	8-K	Jul 10, 2026	Jul 13, 2026	SEC EDGAR
Current report	8-K	Jul 6, 2026	Jul 10, 2026	SEC EDGAR
Current report	8-K	Jul 8, 2026	Jul 9, 2026	SEC EDGAR
Current report	8-K	Jun 30, 2026	Jul 6, 2026	SEC EDGAR
Current report	8-K	Jul 6, 2026	Jul 6, 2026	SEC EDGAR
Current report	8-K	Jun 24, 2026	Jun 26, 2026	SEC EDGAR
Current report	8-K	Jun 15, 2026	Jun 15, 2026	SEC EDGAR
Current report	8-K	Jun 8, 2026	Jun 12, 2026	SEC EDGAR
Current report	8-K	Jun 1, 2026	Jun 4, 2026	SEC EDGAR
Current report	8-K	Jun 3, 2026	Jun 3, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 20, 2026	SEC EDGAR
Current report	8-K	May 9, 2026	May 15, 2026	SEC EDGAR
Current report	8-K	Apr 28, 2025	May 5, 2026	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2025	Apr 30, 2026	SEC EDGAR
Current report	8-K	Apr 27, 2026	Apr 27, 2026	SEC EDGAR
Current report	8-K	Apr 20, 2026	Apr 24, 2026	SEC EDGAR
Current report	8-K	Apr 17, 2026	Apr 21, 2026	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Endovia Health Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Jul 27, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EDVA.

Compare: EDVA vs YHC · EDVA vs RAKR · EDVA vs MDWK · EDVA vs MOJO · EDVA vs IBG

Revenue growth-90.9% · median -27.0%

Gross margin34.7% · median -2.7%

Operating margin-18486.6% · median -524.3%

Net margin-23653.4% · median -866.3%

Company	Revenue	Growth
MOJO	$4.82M	+26.6%
MDWK	$2.24M	-4.4%
YHC	$1.21M	-49.6%
EDVA	$73.07K	-90.9%
RAKR	$34.25K	-76.2%
IBG	–	–

Company

Exchange: NYSE
Industry: Beverages
Fiscal year ends: December 31
Employees: 1
Held by institutions: 4.3%
Auditor: Rose, Snyder & Jacobs LLP
SEC CIK: 1553788

Advertisement
300 × 250

See a number that looks wrong?